pyrrolidine dithiocarbamate has been researched along with ATLL in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, A; Arima, M; Arima, N; Ezinne, CC; Fujino, S; Hachiman, M; Hamada, H; Hayashida, M; Inoue, H; Kamada, Y; Kuroki, A; Nakamura, D; Okada, S; Suzuki, S; Tabuchi, T; Yoshimitsu, M | 1 |
| Akimoto, M; Arima, N; Arimura, K; Hagiwara, T; Hamada, H; Kukita, T; Matsushita, K; Orihara, K; Ozaki, A; Sakaki, Y; Tei, C; Tokito, Y | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and ATLL
| Article | Year |
|---|---|
A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.
Topics: Adult; Animals; Antioxidants; Heterografts; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Mutant Strains; Neoplasm Transplantation; Pyrrolidines; Thiocarbamates; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells.
Topics: Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Line; G1 Phase; Gene Products, tax; Humans; Leukemia-Lymphoma, Adult T-Cell; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrrolidines; Thiocarbamates; Thymidine | 2004 |